FATE short interest
Fate Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 10,759,313 |
|---|---|
| Change vs prior report | 1,372,862 (+14.6%) |
| Change over six months | +9.1% |
| Days to cover | 5.27 (sector: 3.78) |
| Average daily volume | 2,041,291 |
| Rank in Healthcare | #389 of 922 by days to cover |
FATE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 10,759,313 | +14.6% | 5.27 | 2,041,291 |
| 2026-09-15 | 9,386,451 | +3.0% | 10.50 | 893,769 |
| 2026-08-31 | 9,111,011 | +7.1% | 6.23 | 1,462,950 |
| 2026-08-14 | 8,508,135 | +10.8% | 3.28 | 2,593,866 |
| 2026-07-31 | 7,679,112 | +5.0% | 4.58 | 1,675,422 |
| 2026-07-15 | 7,315,037 | -1.6% | 1.98 | 3,690,730 |
| 2026-06-30 | 7,432,049 | -31.3% | 1.22 | 6,076,171 |
| 2026-06-15 | 10,821,669 | +1.2% | 2.99 | 3,616,075 |
| 2026-05-29 | 10,697,112 | +10.0% | 2.07 | 5,176,029 |
| 2026-05-15 | 9,728,302 | -5.1% | 1.98 | 4,914,298 |
| 2026-04-30 | 10,255,224 | -0.2% | 9.30 | 1,102,342 |
| 2026-04-15 | 10,275,369 | +4.2% | 8.17 | 1,257,012 |
| 2026-03-31 | 9,857,461 | +5.8% | 6.64 | 1,483,946 |
| 2026-03-13 | 9,318,720 | -2.6% | 6.59 | 1,414,882 |
| 2026-02-27 | 9,563,527 | -14.1% | 5.47 | 1,749,529 |
| 2026-02-13 | 11,128,203 | -2.5% | 7.46 | 1,492,464 |
| 2026-01-30 | 11,408,582 | -0.3% | 5.64 | 2,021,824 |
| 2026-01-15 | 11,440,395 | +13.7% | 7.27 | 1,573,325 |
| 2025-12-31 | 10,065,114 | +14.1% | 6.45 | 1,559,295 |
| 2025-12-15 | 8,817,939 | +7.7% | 7.68 | 1,148,798 |
| 2025-11-28 | 8,184,722 | +7.9% | 7.46 | 1,096,653 |
| 2025-11-14 | 7,586,108 | +11.0% | 3.80 | 1,994,485 |
| 2025-10-31 | 6,831,984 | -9.4% | 3.09 | 2,212,105 |
| 2025-10-15 | 7,544,331 | -5.6% | 2.07 | 3,650,630 |
| 2025-09-30 | 7,992,013 | -19.1% | 3.68 | 2,170,112 |
import finzdata as yf
yf.Ticker("FATE").short_interest # every report since 2017
yf.Client().short_interest(["FATE"], start="2018-01-01")Healthcare short interest · FATE price history · Who owns FATE · All short interest